Condition: Mood Disorders · Anxiety Disorders · Psychotic Disorders · Sponsor: Parnassia Groep
A 24-week, patient- and rater-blinded, two-arm, parallel-group controlled, and multi-centre randomized clinical trial (RCT) to establish the benefits of pharmacogenetics-informed pharmacotherapy versus dosing as usual (DAU) in psychiatric patients suffering from mood, anxiety, or psychotic disorders.
This description comes directly from the study's public registry record.
Roos van Westrhenen, Professor (MD&PhD) · +31 883583398 · r.vanwestrhenen@psyq.nl
Margriet Boerman, Contact person · 31657940368 · farmacogenetica@parnassiagroep.nl
Always discuss trial participation with your own doctor first.
| SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences | Syracuse, New York, United States | Not Yet Recruiting |
| University Hospital Bonn, Department of Psychiatry and Psychotherapy | Bonn, Germany | Recruiting |
| Ludwig-Maximilian University, University Hospital, Institute of Psychiatric Phenomics and Genomics (IPPG) | München, Germany | Recruiting |
| Parnassia Psychiatric Institute, Department of Psychiatry | Amsterdam, Netherlands | Recruiting |
| Maastricht University, Department of Psychiatry and Neuropsychology | Maastricht, Netherlands | Recruiting |
| Babeş-Bolyai University, Department of Clinical Psychology and Psychotherapy | Cluj-Napoca, Romania | Recruiting |
| University of Belgrade, Faculty of Pharmacy | Belgrade, Serbia | Recruiting |
| Fundació Clínic per a la Recerca Biomèdica, Department of Psychiatry and Psychology, Hospital Clínic | Barcelona, Spain | Recruiting |
| King's College, Institute of Psychiatry, Psychology & Neuroscience | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05656469